• 1
    Mithoefer K, Williams RJ III, Warren RF, Potter HG, Spock CR, Jones EC, et al. The microfracture technique for the treatment of articular cartilage lesions in the knee: a prospective cohort study. J Bone Joint Surg Am 2005; 87: 191120.
  • 2
    Henderson IJ, La Valette DP. Subchondral bone overgrowth in the presence of full-thickness cartilage defects in the knee. Knee 2005; 12: 43540.
  • 3
    Kreuz PC, Steinwachs MR, Erggelet C, Krause SJ, Konrad G, Uhl M, et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 2006; 14: 111925.
  • 4
    Minas T, Gomoll AH, Rosenberger R, Royce RO, Bryant T. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques. Am J Sports Med 2009; 37: 9028.
  • 5
    Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun 1991; 175: 9717.
  • 6
    Hiraki Y, Kono T, Sato M, Shukunami C, Kondo J. Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I. FEBS Lett 1997; 415: 3214.
  • 7
    Shukunami C, Iyama K, Inoue H, Hiraki Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int J Dev Biol 1999; 43: 3949.
  • 8
    Blanke M, Carl HD, Klinger P, Swoboda B, Hennig F, Gelse K. Transplanted chondrocytes inhibit endochondral ossification within cartilage repair tissue. Calcif Tissue Int 2009; 85: 42133.
  • 9
    Kay JD, Gouze E, Oligino TJ, Gouze JN, Watson RS, Levings PP, et al. Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus. J Gene Med 2009; 11: 60514.
  • 10
    McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 2001; 8: 124854.
  • 11
    Steinert AF, Noth U, Tuan RS. Concepts in gene therapy for cartilage repair. Injury 2008; 39 Suppl 1: S97113.
  • 12
    Gelse K, Olk A, Eichhorn S, Swoboda B, Schoene M, Raum K. Quantitative ultrasound biomicroscopy for the analysis of healthy and repair cartilage tissue. Eur Cell Mater 2010; 19: 5871.
  • 13
    Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc 2006; 1: 141228.
  • 14
    Gelse K, Muhle C, Franke O, Park J, Jehle M, Durst K, et al. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 2008; 58: 47588.
  • 15
    Grimmer C, Pfander D, Swoboda B, Aigner T, Mueller L, Hennig FF, et al. Hypoxia-inducible factor 1α is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum 2007; 56: 408494.
  • 16
    Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al. Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994; 94: 230716.
  • 17
    Kitahara H, Hayami T, Tokunaga K, Endo N, Funaki H, Yoshida Y, et al. Chondromodulin-I expression in rat articular cartilage. Arch Histol Cytol 2003; 66: 2218.
  • 18
    Sanz L, Pascual M, Munoz A, Gonzalez MA, Salvador CH, Alvarez-Vallina L. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. Microvasc Res 2002; 63: 3359.
  • 19
    Mainil-Varlet P, Aigner T, Brittberg M, Bullough P, Hollander A, Hunziker E, et al, International Cartilage Repair Society. Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am 2003; 85-A Suppl 2: 4557.
  • 20
    Hiraki Y, Mitsui K, Endo N, Takahashi K, Hayami T, Inoue H, et al. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur J Biochem 1999; 260: 86978.
  • 21
    Girkontaite I, Frischholz S, Lammi P, Wagner K, Swoboda B, Aigner T, et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996; 15: 2318.
  • 22
    O'Driscoll SW, Marx RG, Fitzsimmons JS, Beaton DE. Method for automated cartilage histomorphometry. Tissue Eng 1999; 5: 1323.
  • 23
    Mera H, Kawashima H, Yoshizawa T, Ishibashi O, Ali MM, Hayami T, et al. Chondromodulin-1 directly suppresses growth of human cancer cells. BMC Cancer 2009; 9: 166.
  • 24
    Steinert AF, Proffen B, Kunz M, Hendrich C, Ghivizzani SC, Noth U, et al. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 2009; 11: R148.
  • 25
    Zimmermann P, Boeuf S, Dickhut A, Boehmer S, Olek S, Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum 2008; 58: 274353.
  • 26
    Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005; 75: 20012.
  • 27
    Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006; 97: 3344.
  • 28
    Lafont JE, Talma S, Murphy CL. Hypoxia-inducible factor 2α is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum 2007; 56: 3297306.
  • 29
    Gelse K, Muhle C, Knaup K, Swoboda B, Wiesener M, Hennig F, et al. Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1α activity. Osteoarthritis Cartilage 2008; 16: 145765.
  • 30
    Lafont JE, Talma S, Hopfgarten C, Murphy CL. Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways. J Biol Chem 2008; 283: 477886.
  • 31
    Gelse K, Pfander D, Obier S, Knaup KX, Wiesener M, Hennig FF, et al. Role of hypoxia-inducible factor 1α in the integrity of articular cartilage in murine knee joints. Arthritis Res Ther 2008; 10: R111.
  • 32
    Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E. HIF1α regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 2007; 134: 391728.
  • 33
    Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P, et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 2005; 37: 31322.
  • 34
    Shukunami C, Hiraki Y. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation. Osteoarthritis Cartilage 2001; 9 Suppl A: S91101.
  • 35
    Pfander D, Cramer T, Deuerling D, Weseloh G, Swoboda B. Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis 2000; 59: 44854.
  • 36
    Negishi Y, Ui N, Nakajima M, Kawashima K, Maruyama K, Takizawa T, et al. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem 2001; 276: 3324956.
  • 37
    Stewart MC, Farnum CE, MacLeod JN. Expression of p21CIP1/WAF1 in chondrocytes. Calcif Tissue Int 1997; 61: 199204.
  • 38
    Mikami Y, Asano M, Honda MJ, Takagi M. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 2010; 223: 12333.
  • 39
    Ben-Eliezer M, Phillip M, Gat-Yablonski G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 2007; 32; 23544.
  • 40
    Hayami T, Funaki H, Yaoeda K, Mitui K, Yamagiwa H, Tokunaga K, et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol 2003; 30: 220717.
  • 41
    Walsh DA, Bonnet CS, Turner EL, Wilson D, Situ M, McWilliams DF. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007; 15: 74351.
  • 42
    Von der Mark K, Kirsch T, Nerlich A, Kuss A, Weseloh G, Gluckert K, et al. Type X collagen synthesis in human osteoarthritic cartilage: indication of chondrocyte hypertrophy. Arthritis Rheum 1992; 35: 80611.